Airway epithelial cell-specific delivery of lipid nanoparticles loading siRNA for asthma treatment

被引:17
|
作者
Zhang, Mengjun [1 ]
Jiang, Huiyang [1 ]
Wu, Lan [1 ]
Lu, Haoyu [1 ]
Bera, Hriday [1 ,2 ]
Zhao, Xing [1 ]
Guo, Xiong [1 ]
Liu, Xulu [1 ]
Cun, Dongmei [1 ]
Yang, Mingshi [1 ,3 ]
机构
[1] Shenyang Pharmaceut Univ, Wuya Coll Innovat, Wenhua Rd, 103, Shenyang 110016, Peoples R China
[2] Dr BC Roy Coll Pharm & Allied Hlth Sci, Durgapur 713212, West Bengal, India
[3] Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, Univ Pk 2, DK-2100 Copenhagen, Denmark
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
Pulmonary delivery; siRNA; Lipid nanoparticles; Asthma; Airway epithelial cells; THYMIC STROMAL LYMPHOPOIETIN; IN-VIVO; ICAM-1; EXPRESSION; GENE DELIVERY; PULMONARY; INFLAMMATION; MACROPHAGES; RECEPTOR; MUCUS; RESPONSES;
D O I
10.1016/j.jconrel.2022.10.020
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
With specific and inherent mRNA cleaving activity, small interfering RNA (siRNA) has been deemed promising therapeutics to reduce the exacerbation rate of asthma by inhibiting the expression and release of proin-flammatory cytokines from airway epithelial cells (AECs). To exert the therapeutic effects of siRNA drugs, nano -formulations with high efficiency and safety are required to deliver these nucleic acids to the target cells. Herein, we exploited novel inhaled lipid nanoparticles (LNPs) targeting intercellular adhesion molecule-1 (ICAM-1) receptors on the apical side of AECs. This delivery system is meant to enhance the specific delivery efficiency of siRNA in AECs to prevent the expression of proinflammatory cytokines in AECs and the concomitant symptoms in parallel. A cyclic peptide that resembles part of the capsid protein of rhinovirus and binds to ICAM-1 receptors was initially conjugated with cholesterol and subsequently assembled with ionizable cationic lipids to form the LNPs (Pep-LNPs) loaded with siRNA against thymic stromal lymphopoietin (TSLP siRNA). The obtained Pep-LNPs were subjected to thorough characterization and evaluations in vitro and in vivo. Pep-LNPs significantly enhanced cellular uptake and gene silencing efficiency in human epithelial cells expressing ICAM-1 in vitro, exhibited AEC-specific delivery and improved the gene silencing effect in ovalbumin-challenged asthmatic mice after pulmonary administration. More importantly, Pep-LNPs remarkably downregulated the expression of TSLP in AECs, effectively alleviated inflammatory cell infiltration, and reduced the secretion of other proinflammatory cytokines, including IL-4 and IL-13, as well as mucus production in asthmatic mice. This study demonstrates that Pep-LNPs are safe and efficient to deliver siRNA drugs to asthmatic AECs and could potentially alleviate allergic asthma by inhibiting the overexpression of proinflammatory cytokines in the airway.
引用
收藏
页码:422 / 437
页数:16
相关论文
共 50 条
  • [41] Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity
    Whitehead, Kathryn A.
    Dorkin, J. Robert
    Vegas, Arturo J.
    Chang, Philip H.
    Veiseh, Omid
    Matthews, Jonathan
    Fenton, Owen S.
    Zhang, Yunlong
    Olejnik, Karsten T.
    Yesilyurt, Volkan
    Chen, Delai
    Barros, Scott
    Klebanov, Boris
    Novobrantseva, Tatiana
    Langer, Robert
    Anderson, Daniel G.
    NATURE COMMUNICATIONS, 2014, 5
  • [42] Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling
    Sahay, Gaurav
    Querbes, William
    Alabi, Christopher
    Eltoukhy, Ahmed
    Sarkar, Sovan
    Zurenko, Christopher
    Karagiannis, Emmanouil
    Love, Kevin
    Chen, Delai
    Zoncu, Roberto
    Buganim, Yosef
    Schroeder, Avi
    Langer, Robert
    Anderson, Daniel G.
    NATURE BIOTECHNOLOGY, 2013, 31 (07) : 653 - U119
  • [43] Lipid Nanoparticles as a Platform for miRNA and siRNA Delivery in Hepatocellular Carcinoma
    Dogheim, Gaidaa M.
    Chinnam, Sampath
    Amralla, Mohamed T.
    CURRENT DRUG DELIVERY, 2024,
  • [44] Oral delivery of siRNA lipid nanoparticles: Fate in the GI tract
    Ball, Rebecca L.
    Bajaj, Palak
    Whitehead, Kathryn A.
    SCIENTIFIC REPORTS, 2018, 8
  • [45] Mechanisms of Airway Epithelial Cell Reprogramming in Asthma
    Bonser, L. R.
    Eckalbar, W.
    Zeng, X.
    Siddiqui, S.
    Pollack, J.
    Koh, K.
    Zlock, L.
    Finkbeiner, W. E.
    Bhakta, N. R.
    Woodruff, P.
    Ahituv, N.
    Erle, D. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [46] The Role of Airway Epithelial Cell Alarmins in Asthma
    Whetstone, Christiane E.
    Ranjbar, Maral
    Omer, Hafsa
    Cusack, Ruth P.
    Gauvreau, Gail M.
    CELLS, 2022, 11 (07)
  • [47] Role of airway epithelial cell miRNAs in asthma
    Boateng, Eistine
    Kovacevic, Draginja
    Oldenburg, Vladimira
    Radinger, Madeleine
    Krauss-Etschmann, Susanne
    FRONTIERS IN ALLERGY, 2022, 3
  • [48] Epithelial cell modulation of airway fibrosis in asthma
    Olman, MA
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2003, 28 (02) : 125 - 128
  • [49] In Vivo Specific Delivery of c-Met siRNA to Glioblastoma Using Cationic Solid Lipid Nanoparticles
    Jin, Juyoun
    Bae, Ki Hyun
    Yang, Heekyoung
    Lee, Se Jeong
    Kim, Hyein
    Kim, Yonghyun
    Joo, Kyeung Min
    Seo, Soo Won
    Park, Tae Gwan
    Nam, Do-Hyun
    BIOCONJUGATE CHEMISTRY, 2011, 22 (12) : 2568 - 2572
  • [50] Evaluation of liver specific ionizable lipid nanocarrier in the delivery of siRNA
    Rana, Shilpa
    Bhatnagar, Archana
    Singh, Suman
    Prabhakar, Nirmal
    CHEMISTRY AND PHYSICS OF LIPIDS, 2022, 246